DANIEL LEFLER: Open Payments
NPI 1033620315 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,620 in 36 payments from 15 companies in 2025. Trend: 2023 $1,894 · 2024 $2,422 · 2025 $2,620
Food & beverage: $2,071Travel & lodging: $550
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $811 |
| Insulet Corporation | 5 | $307 |
| Corcept Therapeutics | 3 | $286 |
| Tandem Diabetes Care, Inc. | 3 | $206 |
| SANOFI-AVENTIS U.S. LLC | 1 | $157 |
| Enterra Medical, Inc. | 1 | $156 |
| Ascendis Pharma Endocrinology Inc | 4 | $155 |
| Dexcom, Inc. | 3 | $146 |
| Lilly USA, LLC | 2 | $122 |
| Amgen Inc. | 1 | $109 |
Products named: MINIMED 780G, OMNIPOD, Korlym, t:slim X2 Insulin Pump with Control-IQ, TZIELD, Yorvipath, Dexcom G6 Transmitter, TEPEZZA.
Industry payments across ID — which companies pay providers there.
